158 related articles for article (PubMed ID: 9106907)
1. Stimulus and response factors affecting the development of behavioral sensitization to apomorphine.
Mattingly BA; Koch C; Osborne FH; Gotsick JE
Psychopharmacology (Berl); 1997 Mar; 130(2):109-16. PubMed ID: 9106907
[TBL] [Abstract][Full Text] [Related]
2. Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization.
Braga PQ; Dias FR; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2009 Aug; 93(2):128-33. PubMed ID: 19414026
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
Mattingly BA; Caudill A; Abel M
Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394
[TBL] [Abstract][Full Text] [Related]
4. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
5. The expression of locomotor sensitization to apomorphine is dependent on time interval between injection and testing.
Braga PQ; Galvanho JP; Bloise E; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2009 Jan; 91(3):278-82. PubMed ID: 18675843
[TBL] [Abstract][Full Text] [Related]
6. Drug conditioning induced by intrastriatal apomorphine administration.
Pinheiro Carrera M; Brunhara FC; Schwarting RK; Tomaz C
Brain Res; 1998 Apr; 790(1-2):60-6. PubMed ID: 9593824
[TBL] [Abstract][Full Text] [Related]
7. Repeated pre-trial and post-trial low and high dose apomorphine treatments induce comparable inhibitory/excitatory sensitization and conditioned drug effects.
Santos BG; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2018 Dec; 175():108-115. PubMed ID: 30267795
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
Mattingly BA; Himmler C; Bonta T; Rice LL
Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
[TBL] [Abstract][Full Text] [Related]
9. Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine.
Mattingly BA; Fields SE; Langfels MS; Rowlett JK; Robinet PM; Bardo MT
Psychopharmacology (Berl); 1996 May; 125(1):33-42. PubMed ID: 8724446
[TBL] [Abstract][Full Text] [Related]
10. Post-trial apomorphine at an autoreceptor dose level can eliminate apomorphine conditioning and sensitization: support for the critical role of dopamine in re-consolidation.
Carrera MP; Carey RJ; Cruz Dias FR; Dos Santos Sampaio MF; de Matos LW
Behav Brain Res; 2013 Jan; 236(1):244-250. PubMed ID: 22759753
[TBL] [Abstract][Full Text] [Related]
11. Post-trial low dose apomorphine prevents the development of morphine sensitization.
de Mello Bastos JM; Leite JB; Samuels RI; Carey RJ; Carrera MP
Behav Brain Res; 2020 Feb; 380():112398. PubMed ID: 31790782
[TBL] [Abstract][Full Text] [Related]
12. Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms.
Braga PQ; Dias FR; Carey RJ; Carrera MP
Behav Brain Res; 2009 Dec; 204(1):169-74. PubMed ID: 19520118
[TBL] [Abstract][Full Text] [Related]
13. Stimulus gated cocaine sensitization: interoceptive drug cue control of cocaine locomotor sensitization.
Carey RJ; DePalma G; Damianopoulos E; Shanahan A
Pharmacol Biochem Behav; 2005 Oct; 82(2):353-60. PubMed ID: 16216323
[TBL] [Abstract][Full Text] [Related]
14. Behavioral sensitization produced by a single administration of apomorphine: implications for the role of Pavlovian conditioning in the mediation of context-specific sensitization.
Bloise E; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2007 Mar; 86(3):449-57. PubMed ID: 17289130
[TBL] [Abstract][Full Text] [Related]
15. Reversal of morphine conditioned behavior by an anti-dopaminergic post-trial drug treatment during re-consolidation.
Leite Junior JB; de Mello Bastos JM; Samuels RI; Carey RJ; Carrera MP
Behav Brain Res; 2019 Feb; 359():771-782. PubMed ID: 30114434
[TBL] [Abstract][Full Text] [Related]
16. Apomorphine locomotor sensitization can be potentiated by environmental change: evidence for a non-Pavlovian associative behavioral contrast factor in sensitization expression.
Coelho GC; Galvanho JP; Carey RJ; Carrera MP
Behav Brain Res; 2011 Jun; 220(1):146-51. PubMed ID: 21295617
[TBL] [Abstract][Full Text] [Related]
17. Drug memory substitution during re-consolidation: a single inhibitory autoreceptor apomorphine treatment given during psychostimulant memory re-consolidation replaces psychostimulant conditioning with conditioned inhibition and reverses psychostimulant sensitization.
de Mello Bastos JM; Dias FR; Alves VH; Carey RJ; Carrera MP
Behav Brain Res; 2014 Mar; 260():139-47. PubMed ID: 24239895
[TBL] [Abstract][Full Text] [Related]
18. Locomotor activity and stereotypy in rats following repeated apomorphine treatments at 1-, 3-, or 7-day intervals.
Mattingly BA; Gotsick JE; Marin C
Pharmacol Biochem Behav; 1988 Dec; 31(4):871-5. PubMed ID: 3252279
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation.
Rowlett JK; Mattingly BA; Bardo MT
Synapse; 1993 Jun; 14(2):160-8. PubMed ID: 8332946
[TBL] [Abstract][Full Text] [Related]
20. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.
Mattingly BA; Rowlett JK; Lovell G
Psychopharmacology (Berl); 1993; 110(3):320-6. PubMed ID: 7831425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
